References
- Angulo, P. (2002). Non-alcoholic Fatty Liver Disease. New Engl. J Med., 346, 1221-1231. https://doi.org/10.1056/NEJMra011775
- Bellentani, S., Saccoccio, G., Masutti, F., Croce, L.S., Brandi, G., Sasso, F., Cristanini, G. and Tiribelli, C. (2000). Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann. Intern. Med., 132, 112-117.
- Choi, S.I., Jeong, C.S., Cho, S.Y. and Lee, Y.S. (2007). Mechanism of apoptosis induced by apigenin in HepG2 human hepatoma cells: involvement of reactive oxygen species generated by NADPH oxidase. Arch. Pharm. Res., 30, 1328-1335. https://doi.org/10.1007/BF02980274
- Costet, P., Legendre, C., More, J., Edgar, A., Galtier, P. and Pineau, T. (1998). Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol. Chem., 273, 29577-29585. https://doi.org/10.1074/jbc.273.45.29577
- Deboyser, D., Goethals, F., Krack, G. and Roberfroid, M. (1989). Investigation into the mechanism of tetracycline-induced steatosis: study in isolated hepatocytes. Toxicol. Appl. Pharmacol., 97, 473-479. https://doi.org/10.1016/0041-008X(89)90252-4
- Domitroviae, R., Jakovac, H., Tomac, J. and Sain, I. (2009). Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin. Toxicol. Appl. Pharmacol., 241, 311-321. https://doi.org/10.1016/j.taap.2009.09.001
- Eadie, M.J., Hooper, W.D. and Dickinson, R.G. (1988). Valproateassociated hepatotoxicity and its biochemical mechanisms. Med. Toxicol. Adverse Drug Exp., 3, 85-106. https://doi.org/10.1007/BF03259935
- Fromenty, B., Fisch, C., Labbe, G., Degott, C., Deschamps, D., Berson, A., Letteron, P. and Pessayre, D. (1990). Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J. Pharmacol. Exp. Ther., 255, 1371-1376.
- Gomez-Lechon, M.J., Donato, M.T., Martínez-Romero, A., Jimenez, N., Castell, J.V. and O'Connor, J.E. (2007). A human hepatocellular in vitro model to investigate steatosis. Chem. Biol. Interact., 165, 106-116. https://doi.org/10.1016/j.cbi.2006.11.004
- Horton, J.D., Bashmakov, Y., Shimomura, I. and Shimano, H. (1998). Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc. Natl. Acad. Sci. U.S.A., 95, 5987-5992. https://doi.org/10.1073/pnas.95.11.5987
- Kersten, S., Seydoux, J., Peters, J.M., Gonzalez, F.J., Desvergne, B. and Wahli, W. (1999). Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103, 1489-1498. https://doi.org/10.1172/JCI6223
- Liang, C.P. and Tall, A.R. (2001). Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver. J. Biol. Chem., 276, 49066-49076. https://doi.org/10.1074/jbc.M107250200
- McMillian, M.K., Grant, E.R., Zhong, Z., Parker, J.B., Li, L., Zivin, R.A., Burczynski, M.E. and Johnson M.D. (2001). Nile Red binding to HepG2 cells: an improved assay for in vitro studies of hepatosteatosis. In Vitr. Mol. Toxicol. 14, 177-190. https://doi.org/10.1089/109793301753407948
- Shimomura, I., Matsuda, M., Hammer, R.E., Bashmakov, Y., Brown, M.S. and Goldstein, J.L. (2000). Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell, 6, 77-86. https://doi.org/10.1016/S1097-2765(00)00009-5
- Sudhahar, V., Kumar, S.A., Varalakshmi, P. and Sundarapandiyan, R. (2007). Mitigating role of lupeol and lupeol linoleate on hepatic lipemic-oxidative injury and lipoprotein peroxidation in experimental hypercholesterolemia. Mol. Cell Biochem., 295, 189-198. https://doi.org/10.1007/s11010-006-9288-2
- Tiniakos, D.G. (2009). Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients. Gastroenterol. Clin. Biol., 33, 930-939. https://doi.org/10.1016/j.gcb.2009.05.009
- Yahagi, N., Shimano, H., Hasty, A.H., Matsuzaka, T., Ide, T., Yoshikawa, T., Amemiya-Kudo, M., Tomita, S., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., Osuga, J., Harada, K., Gotoda, T., Nagai, R., Ishibashi, S. and Yamada, N. (2002). Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol. Chem., 277, 19353-19357. https://doi.org/10.1074/jbc.M201584200
Cited by
- Targeting FASN in Breast Cancer and the Discovery of Promising Inhibitors from Natural Products Derived from Traditional Chinese Medicine vol.2014, pp.1741-4288, 2014, https://doi.org/10.1155/2014/232946
- Natural Substance MS-10 Improves Women's Health via Regulation of Estrogen Receptor vol.45, pp.6, 2016, https://doi.org/10.3746/jkfn.2016.45.6.903
- extract in mice based on ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry pp.1537-6524, 2017, https://doi.org/10.1080/15376516.2017.1351017